Loading: 100%
PFIZER INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter New York, United States of AmericaNew York, United States of Americano data available
Employees 96,500 (as per Q2 2017)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker PFEno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1728,030,833,636,439,2
datesClosing price (adj.)
13.10.201736.34
11.10.201736.45
04.10.201735.96
27.09.201735.45
20.09.201735.99
13.09.201735.06
06.09.201733.99
30.08.201733.45
23.08.201733.24
16.08.201733.36
09.08.201733.45
02.08.201732.92
26.07.201732.57
19.07.201733.30
12.07.201732.90
05.07.201733.32
27.06.201733.44
20.06.201733.24
13.06.201732.27
06.06.201731.76
30.05.201731.82
23.05.201731.83
16.05.201732.29
09.05.201732.74
02.05.201732.97
25.04.201733.11
18.04.201733.19
11.04.201733.28
04.04.201733.68
28.03.201733.51
21.03.201733.59
14.03.201733.57
07.03.201733.34
28.02.201733.47
21.02.201732.98
14.02.201732.12
07.02.201731.47
31.01.201730.81
24.01.201730.25
17.01.201731.13
10.01.201732.47
03.01.201732.04
27.12.201631.59
19.12.201631.88
12.12.201631.46
05.12.201630.68
28.11.201630.63
21.11.201630.66
14.11.201631.44
07.11.201629.21
31.10.201630.49
24.10.201630.89
17.10.201631.25
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
36.34n/a
Market Capitalisation
in million USD
223,770n/a
Enterprise Value
in million USD
253,468n/a
Common Shares Outstanding
as per May 4, 2015
6,157,669,933n/a
Preferred Shares Outstanding
as per May 4, 2015
n/a
Average Basic Shares Outstanding
TTM
6,025,500,000n/a
Average Diluted Shares Outstanding
TTM
6,103,750,000n/a
Index Membership
n/a
Business Summary
Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 52,347n/a
Gross Profit 40,909n/a
Operating Income 13,832n/a
EBITDA 19,906n/a
Net Profit 8,322n/a
Balance Sheet
Cash and Cash Equivalents 14,333n/a
Receivables 9,476n/a
Total Current Assets 36,386n/a
PP&E 13,386n/a
Total Assets 168,560n/a
Accounts Payable 3,439n/a
Current Debt 9,514n/a
Total Current Liabilities 27,182n/a
Long-Term Debt 34,191n/a
Total Liabilities 109,864n/a
Total Equity 58,695n/a
Cash Flow
Depreciation & Amortisation 6,074n/a
Change in Working Capital -586n/a
Operating Cash Flow 15,328n/a
Net Change in PP&E and Intangibles -2,048n/a
Investing Cash Flow -4,455n/a
Dividends Paid -7,497n/a
Financing Cash Flow -11,590n/a
Total Change in Cash -827n/a
Free Cash Flow 15,449n/a
Profitability Ratios
Gross Margin 78.1%n/a
Operating Margin 26.4%n/a
Net Profit Margin 15.9%n/a
Return on Equity 14.2%n/a
Return on Assets 5.0%n/a
Per Share Figures
Basic EPS 1.38n/a
Diluted EPS 1.36n/a
Sales per Share 8.69n/a
Book Value per Share 9.68n/a
FCF per Share 2.56n/a
Dividends per Share 1.24n/a
Price Multiples
Price to Earnings Ratio 26.31n/a
Price to Sales Ratio 4.18n/a
Price to Book Value 3.73n/a
Price to Free Cash Flow 14.17n/a
Valuation Metrics
EV/EBITDA 12.73n/a
EV/Sales 4.84n/a
Book to Market Value 0.26n/a
Other Ratios
Current Ratio 133.9%n/a
Liabilities to Equity Ratio 187.2%n/a
Debt to Assets Ratio 25.9%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
48,418
48,296
49,269
65,165
61,035
54,657
51,584
49,605
48,851
52,824
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
0
Cost of revenue
-11,239
-8,112
-8,459
-14,788
-12,500
-9,821
-9,586
-9,577
-9,648
-12,329
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
37,179
40,184
40,810
50,377
48,535
44,836
41,998
40,028
39,203
40,495
Other Operating Income
0
0
0
0
0
0
0
0
0
0
Operating Expenses
-26,843
-25,150
-25,453
-33,820
-31,727
-27,762
-25,632
-26,529
-26,227
-26,765
Selling, General & Administrative
-15,626
-14,537
-14,752
-18,973
-17,581
-15,171
-14,355
-14,097
-14,809
-14,837
Selling & Marketing
0
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
0
Research & Development
-8,089
-7,945
-7,824
-9,483
-8,681
-7,482
-6,678
-8,393
-7,690
-7,872
Depreciation & Amortization
-3,128
-2,668
-2,877
-5,364
-5,465
-5,109
-4,599
-4,039
-3,728
-4,056
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
10,336
15,034
15,357
16,557
16,808
17,074
16,366
13,499
12,976
13,730
Non-Operating Income (Loss)
1,759
-2,032
-285
-3,941
-2,486
-4,022
532
-1,009
-2,860
-3,655
Interest Expense, net
0
0
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
1,759
-2,032
-285
-3,941
-2,486
-4,022
532
-1,009
-2,860
-3,655
Pretax Income (Loss), Adjusted
12,095
13,002
15,072
12,616
14,322
13,052
16,898
12,490
10,116
10,075
Abnormal Gains (Losses)
-2,817
-3,308
-4,398
-3,145
-2,841
-1,810
-1,182
-250
-1,152
-1,724
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
9,278
9,694
10,674
9,471
11,481
11,242
15,716
12,240
8,964
8,351
Income Tax (Expense) Benefit, net
-1,023
-1,645
-2,145
-1,153
-3,621
-2,221
-4,306
-3,120
-1,990
-1,123
Current Income Tax
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
8,255
8,049
8,529
8,318
7,860
9,021
11,410
9,120
6,974
7,228
Net Extraordinary Gains (Losses)
-69
78
114
-30
2,189
5,577
10,662
49
11
17
Discontinued Operations
-69
78
114
-30
2,189
5,577
10,662
49
11
17
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
8,186
8,127
8,643
8,288
10,049
14,598
22,072
9,169
6,985
7,245
Minority Interest
-42
-23
-8
-31
-40
-28
-69
-32
-26
-31
Net Income
8,144
8,104
8,635
8,257
10,009
14,570
22,003
9,137
6,959
7,214
Preferred Dividends
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
8,144
8,104
8,635
8,257
10,009
14,570
22,003
9,137
6,959
7,214
Remarks
restated on Feb 26, 2010 n/a
calculated values,
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 28, 2012 n/a
calculated values,
restated on Feb 28, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
23,731
25,969
28,012
26,452
32,399
32,408
36,122
23,290
17,850
Cash & Cash Equivalents
n/a
2,122
1,978
1,735
3,182
10,081
2,183
3,343
3,641
2,595
Short Term Investments
n/a
21,609
23,991
26,277
23,270
22,318
30,225
32,779
19,649
15,255
Accounts & Notes Receivable
n/a
8,958
14,645
13,380
13,058
10,675
9,357
8,401
8,176
8,225
Accounts Receivable, Net
n/a
8,958
14,645
13,380
13,058
10,675
9,357
8,401
8,176
8,225
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
0
Inventories
n/a
4,381
12,403
8,275
6,610
6,076
6,166
5,663
7,513
6,783
Raw Materials
n/a
0
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
6,006
8,653
11,346
14,697
15,681
8,313
5,409
4,825
6,091
Prepaid Expenses
n/a
0
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
148
496
1,439
5,317
5,944
0
0
9
801
Miscellaneous Short Term Assets
n/a
5,858
8,157
9,907
9,380
9,737
8,313
5,409
4,816
5,290
Total Current Assets
n/a
43,076
61,670
61,013
60,817
64,831
56,244
55,595
43,804
38,949
Property, Plant & Equipment, Net
n/a
13,287
22,780
18,645
15,921
13,213
12,397
11,762
13,766
13,318
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
11,478
13,122
9,747
9,814
14,149
16,406
17,518
15,999
7,116
Long Term Investments
n/a
0
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
43,307
115,377
105,609
101,450
93,605
87,054
82,692
93,812
112,232
Intangible Assets
n/a
17,721
68,015
57,555
51,184
45,146
39,385
35,166
40,356
52,648
Goodwill
n/a
21,464
42,376
43,928
44,569
43,661
42,519
42,069
48,242
54,449
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
4,122
4,986
4,126
5,697
1,565
1,554
1,944
1,794
1,812
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
0
3,233
3,596
3,513
3,420
3,323
Total Noncurrent Assets
n/a
68,072
151,279
134,001
127,185
120,967
115,857
111,972
123,577
132,666
Total Assets
n/a
111,148
212,949
195,014
188,002
185,798
172,101
167,567
167,381
171,615
Liabilities and owners' equity
Payables & Accruals
n/a
6,233 6233000000
18,173 18173000000
8,626 8626000000
8,603 8603000000
7,508 7508000000
7,367 7367000000
7,293 7293000000
8,249 8249000000
9,404 9404000000
Accounts Payable
n/a
1,751 1751000000
4,370 4370000000
3,994 3994000000
3,678 3678000000
2,921 2921000000
3,234 3234000000
3,210 3210000000
3,620 3620000000
4,536 4536000000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
2,159 2159000000
1,454 1454000000
1,601 1601000000
1,796 1796000000
1,733 1733000000
1,663 1663000000
1,711 1711000000
1,852 1852000000
1,944 1944000000
Other Payables & Accruals
n/a
2,323 2323000000
12,349 12349000000
3,031 3031000000
3,129 3129000000
2,854 2854000000
2,470 2470000000
2,372 2372000000
2,777 2777000000
2,924 2924000000
Short Term Debt
n/a
9,320 9320000000
5,469 5469000000
5,603 5603000000
4,016 4016000000
6,424 6424000000
6,027 6027000000
5,141 5141000000
10,159 10159000000
10,688 10688000000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
11,456 11456000000
13,583 13583000000
14,407 14407000000
16,290 16290000000
15,254 15254000000
9,972 9972000000
9,153 9153000000
10,990 10990000000
11,023 11023000000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
151 151000000
1,224 1224000000
1,442 1442000000
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
11,456 11456000000
13,583 13583000000
14,256 14256000000
15,066 15066000000
13,812 13812000000
9,972 9972000000
9,153 9153000000
10,990 10990000000
11,023 11023000000
Total Current Liabilities
n/a
27,009 27009000000
37,225 37225000000
28,636 28636000000
28,909 28909000000
29,186 29186000000
23,366 23366000000
21,587 21587000000
29,398 29398000000
31,115 31115000000
Long Term Debt
n/a
7,963 7963000000
43,193 43193000000
38,410 38410000000
34,926 34926000000
31,036 31036000000
30,462 30462000000
31,541 31541000000
28,740 28740000000
31,398 31398000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
18,436 18436000000
42,085 42085000000
39,703 39703000000
41,546 41546000000
43,898 43898000000
41,653 41653000000
42,817 42817000000
44,245 44245000000
49,262 49262000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
5,839 5839000000
9,635 9635000000
9,229 9229000000
9,699 9699000000
11,273 11273000000
7,303 7303000000
10,264 10264000000
8,119 8119000000
8,172 8172000000
Pensions
n/a
4,235 4235000000
6,392 6392000000
6,194 6194000000
6,355 6355000000
7,782 7782000000
4,635 4635000000
7,885 7885000000
6,310 6310000000
6,406 6406000000
Other Post-Retirement Benefits
n/a
1,604 1604000000
3,243 3243000000
3,035 3035000000
3,344 3344000000
3,491 3491000000
2,668 2668000000
2,379 2379000000
1,809 1809000000
1,766 1766000000
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
2,959 2959000000
17,839 17839000000
18,628 18628000000
18,861 18861000000
21,193 21193000000
25,590 25590000000
23,317 23317000000
26,877 26877000000
30,753 30753000000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
9,638 9638000000
14,611 14611000000
11,846 11846000000
12,986 12986000000
11,432 11432000000
8,760 8760000000
9,236 9236000000
9,249 9249000000
10,337 10337000000
Total Noncurrent Liabilities
n/a
26,399 26399000000
85,278 85278000000
78,113 78113000000
76,472 76472000000
74,934 74934000000
72,115 72115000000
74,358 74358000000
72,985 72985000000
80,660 80660000000
Total Liabilities
n/a
53,408 53408000000
122,503 122503000000
106,749 106749000000
105,381 105381000000
104,120 104120000000
95,481 95481000000
95,945 95945000000
102,383 102383000000
111,775 111775000000
Preferred Equity
n/a
73 73000000
61 61000000
52 52000000
45 45000000
39 39000000
33 33000000
29 29000000
26 26000000
24 24000000
Share Capital & Additional Paid-In Capital
n/a
70,726 70726000000
70,940 70940000000
71,204 71204000000
71,868 71868000000
73,056 73056000000
77,736 77736000000
79,432 79432000000
81,475 81475000000
83,146 83146000000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-57,391 -57391000000
-21,632 -21632000000
-22,712 -22712000000
-31,801 -31801000000
-40,122 -40122000000
-67,923 -67923000000
-73,021 -73021000000
-79,252 -79252000000
-84,364 -84364000000
Retained Earnings
n/a
49,142 49142000000
40,426 40426000000
42,716 42716000000
46,210 46210000000
54,240 54240000000
69,732 69732000000
72,176 72176000000
71,993 71993000000
71,774 71774000000
Other Equity
n/a
-4,994 -4994000000
219 219000000
-3,447 -3447000000
-4,132 -4132000000
-5,953 -5953000000
-3,271 -3271000000
-7,316 -7316000000
-9,522 -9522000000
-11,036 -11036000000
Equity Before Minority Interest
n/a
57,556 57556000000
90,014 90014000000
87,813 87813000000
82,190 82190000000
81,260 81260000000
76,307 76307000000
71,300 71300000000
64,720 64720000000
59,544 59544000000
Minority Interest
n/a
184 184000000
432 432000000
452 452000000
431 431000000
418 418000000
313 313000000
321 321000000
278 278000000
296 296000000
Total Equity
n/a
57,740 57740000000
90,446 90446000000
88,265 88265000000
82,621 82621000000
81,678 81678000000
76,620 76620000000
71,621 71621000000
64,998 64998000000
59,840 59840000000
Total Liabilities & Equity
n/a
111,148 111148000000
212,949 212949000000
195,014 195014000000
188,002 188002000000
185,798 185798000000
172,101 172101000000
167,566 167566000000
167,381 167381000000
171,615 171615000000
Remarks restated on n/a restated on Feb 26, 2010 n/a restated on Nov 12, 2010 n/a restated on Feb 28, 2012 n/a restated on Feb 28, 2013 n/a restated on Feb 28, 2014 n/a restated on Feb 27, 2015 n/a restated on Feb 29, 2016 n/a restated on Nov 10, 2016 n/a restated on Aug 10, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
8,186
8,127
8,643
8,288
10,049
14,598
22,072
9,168
6,986
7,246
Net Income
0
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
5,200
5,090
4,757
8,399
9,026
7,655
6,410
5,537
5,157
5,757
Non-Cash Items
767
113
-8,800
5,129
-1,368
-3,140
-7,420
754
1,805
2,813
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
-800
4,908
11,987
-10,362
2,533
-2,367
-3,378
1,623
741
85
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
13,353
18,238
16,587
11,454
20,240
16,746
17,684
17,082
14,689
15,901
Change in Fixed Assets & Intangibles
-1,880
-1,701
-1,205
-1,513
-1,882
-1,419
-1,465
-1,583
-1,496
-1,999
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-1,635
-9,357
-6,888
-4,128
-4,620
-11,145
-11,020
-10,718
-9,542
-8,011
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-464
-1,184
-43,123
-273
-906
10,800
-15
-195
-16,466
-18,368
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
0
Other Investing Activities
4,774
-92
20,005
5,422
9,251
7,918
1,956
6,842
24,524
20,566
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
795
-12,334
-31,211
-492
1,843
6,154
-10,544
-5,654
-2,980
-7,812
Dividends Paid
-7,975
-8,541
-5,548
-6,088
-6,234
-6,534
-6,580
-6,609
-6,940
-7,317
Cash From (Repayment of) Debt
4,900
1,906
20,059
-4,152
-5,542
-1,725
6,036
543
1,319
2,573
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-9,994
-500
0
-1,000
-8,847
-7,660
-14,540
-3,998
-4,897
-3,981
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
0
Other Financing Activities
459
74
-91
66
16
-80
109
-123
109
-196
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-12,610
-7,061
14,420
-11,174
-20,607
-15,999
-14,975
-10,187
-10,409
-8,921
Net Cash Before Disc. Operations and FX
1,538
-1,157
-204
-212
1,476
6,901
-7,835
1,241
1,300
-832
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
0
Net Cash Before FX
1,538
-1,157
-204
-212
1,476
6,901
-7,835
1,241
1,300
-832
Effect of Foreign Exchange Rates
41
-127
60
-31
-29
-2
-63
-83
-1,000
-215
Net Changes in Cash
1,579
-1,284
-144
-243
1,447
6,899
-7,898
1,158
300
-1,047
Remarks
restated on Feb 26, 2010 n/a
calculated values,
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 28, 2012 n/a
calculated values,
restated on Feb 28, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo